- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04735341
Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence
August 8, 2022 updated by: Intuitive Surgical
The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Pinehurst, North Carolina, United States, 28374
- FirstHealth of the Carolinas Moore Regional Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects who will undergo an Ion Endoluminal Procedure with a pulmonary nodule, 18 years or older
Description
Inclusion Criteria:
Age of 18 years or older
- Undergoing a lung biopsy procedure with Ion System
- Have peripheral pulmonary lesion (5th bronchial generation or higher)
- Willingness to participate as demonstrated by signing the informed consent
Exclusion Criteria:
Unable to provide informed consent
- Presence of bilateral nodules intended to be biopsied during procedure
- The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy
- Vulnerable population (e.g., prisoners, mentally disabled)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Subjects with planned Ion Endoluminal Procedure with pulmonary nodule
|
Ion Endoluminal Procedure for pulmonary nodule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ion Catheter Shape
Time Frame: Intra-operative
|
The collection of data relating to the Ion catheter shape
|
Intra-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 9, 2020
Primary Completion (ACTUAL)
June 30, 2022
Study Completion (ACTUAL)
June 30, 2022
Study Registration Dates
First Submitted
January 28, 2021
First Submitted That Met QC Criteria
February 2, 2021
First Posted (ACTUAL)
February 3, 2021
Study Record Updates
Last Update Posted (ACTUAL)
August 9, 2022
Last Update Submitted That Met QC Criteria
August 8, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISI-IonLR-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.